Khulud Abudawood

Dr. Khulud Abudawood

College of nursing, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Makkah al Mukarramah, Saudi Arabia
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2022 in Pain Management Nursing
Verified
Journal Article
Closed access
KAKhulud Abudawood
Khulud Abudawood
SYSaunjoo Yoon
Saunjoo Yoon
YYYingwei Yao
Yingwei Yao
Oliver GrundmannOliver Grundmann
Oliver Grundmann
MEMiriam O. Ezenwa
Miriam O. Ezenwa
DWDiana J Wilkie
Diana J Wilkie

22 July 2025 in Archives of Osteoporosis
Verified
Journal Article
Closed access
PDF file
FAFatmah Alsharif
Fatmah Alsharif
FKFathia Khamis Kassem
Fathia Khamis Kassem
HAHamamah Murdi Alzahrani
Hamamah Murdi Alzahrani
RRRufaidah Abdulkareem Rubehan
Rufaidah Abdulkareem Rubehan
SBShahad Ali Baarma
Shahad Ali Baarma
KAKhulud Abudawood
Khulud Abudawood

15 July 2026 in Nursing Reports
Verified
Journal Article
Open access
PDF file
KAKhulud Abudawood
Khulud Abudawood
RARawan Almutairi
Rawan Almutairi
Pain is highly prevalent during hospitalization, and inadequate assessment contributes to avoidable suffering, prolonged length of stay, and increased resource use. Nurses play a central role in pain assessment, timely analgesic administration, patient education, and escalation of care. Background/Objectives: This study assessed nurses’ knowledge and attitudes regarding pain assessment and management and examined perceived causes of delayed pain treatment and perceived barriers to timely pain control at a tertiary hospital in Saudi Arabia. Methods: A descriptive cross-sectional study was conducted in inpatient and outpatient departments at King Abdulaziz Medical City, Jeddah, Saudi Arabia (August–December 2023). Registered nurses providing direct patient care were recruited via convenience sampling. Data were collected using a demographic and clinical practice questionnaire, the Nurses’ Knowledge and Attitudes Survey Regarding Pain (NKASRP), and an adopted instrument assessing perceived causes of delayed pain treatment and perceived barriers. Data were analyzed using descriptive statistics, two-tailed t-tests, one-way ANOVA with assumption checks and post hoc testing, Pearson correlations, and multiple linear regression. Results: A total of 125 nurses participated; 95.2% were female and 80.8% held a bachelor’s degree. The mean NKASRP composite score was 46.69% (SD = 9.90), indicating a suboptimal knowledge-and-attitudes profile. Age group was significantly associated with NKASRP scores (F = 5.136, p = 0.007), and age remained the only significant independent predictor in the multivariable model (b = 0.055, p = 0.006). The most frequently perceived delay was contacting a physician for opioid prescription (58.4%), followed by obtaining opioids from the pharmacy (46.4%). Major perceived barriers included insufficient staff–patient communication (60.0%), insufficient patient knowledge of pain control (52.8%), and inadequate staffing (49.6%). Conclusions: Nurses demonstrated a low composite knowledge-and-attitudes score and reported communication, workflow, and system-related barriers relevant to timely analgesia. These findings support further prospective evaluation of targeted educational and system-level strategies in similar settings.

7 July 2026 in BMC Nursing
Verified
Journal Article
Open access
PDF file
NANaelah Almutairi
Naelah Almutairi
NANoor Alshareef
Noor Alshareef
KAKhulud Abudawood
Khulud Abudawood
Moral distress is an important ethical concern among oncology and hematology nurses and may reduce job satisfaction and retention. This study examined mora

22 July 2026 in The Egyptian Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
RFRazaz Felemban
Razaz Felemban
LALama Aljefri
Lama Aljefri
YSYasmenah Shaheen
Yasmenah Shaheen
GSGadi Sindi
Gadi Sindi
MAMohammed Albadri
Mohammed Albadri
KAKhulud Abudawood
Khulud Abudawood
Objective: Drug-induced liver injury (DILI) is a significant global health concern, and herbal medicines are increasingly being used to treat herb-induced liver injury (HILI). Withania somnifera ( Ashwagandha ), which is widely used for its health benefits, has been associated with emerging cases of liver toxicity. This systematic review synthesizes the literature regarding the clinical presentation, diagnostic findings, treatment strategies, and outcomes of Ashwagandha -induced liver injury. Methods: A systematic search of PubMed, Medline, Google Scholar, ScienceDirect, and Web of Science was conducted following PRISMA guidelines. Case reports and series documenting Ashwagandha -associated liver injury were included. The extracted data included patient demographics, symptoms, liver function tests, imaging findings, treatment interventions, and outcomes. The Joanna Briggs Institute critical appraisal tool was used to assess the quality of the included reports. Results: The analysis was performed on 19 studies involving 26 patients. The mean age was 37.8 ± 15.1 years, with 53.9% of patients being male. The most reported symptoms were jaundice (88.5%) and pruritus (72.9%). Liver injury manifests as hepatocellular, cholestatic, or mixed patterns, with elevated bilirubin, AST, and ALT levels. Most cases demonstrate probable or possible causality on the basis of RUCAM scores (Roussel Uclaf Causality Assessment Method). Discontinuation of Ashwagandha led to recovery in most cases, although severe cases required intensive care or liver transplantation. Conclusion: Despite its apparent safety, Ashwagandha can cause liver damage and injury. These findings underscore the importance of vigilant clinical assessment, early recognition, and prompt discontinuation of the supplement in suspected cases.